GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: example 274 [WO2023133472] | IMM-6-415
Compound class:
Synthetic organic
Comment: Envometinib is the INN for a MEK inhibitor. It was included in WHO INN proposed list 133 (10th July 2025). Chemical structure match in patent WO2023133472 [1] suggests that this might be Immuneering Corporation's MEK clinical lead IMM-6-415.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
[3-[[2-chloro-3-(methylsulfamoylamino)phenyl]methyl]-4-[(dimethylamino)methyl]-2-oxochromen-7-yl] N,N-dimethylcarbamate |
International Nonproprietary Names ![]() |
|
INN number | INN |
13780 | envometinib |
Synonyms ![]() |
example 274 [WO2023133472] | IMM-6-415 |
Database Links ![]() |
|
CAS Registry No. | 2952542-22-0 (source: WHO INN record) |
PubChem CID | 168982960 |
Search Google for chemical match using the InChIKey | UNBQMQJVNBHLAP-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | UNBQMQJVNBHLAP |
Search PubMed clinical trials | envometinib |
Search PubMed titles | envometinib |
Search PubMed titles/abstracts | envometinib |
UniChem Compound Search for chemical match using the InChIKey | UNBQMQJVNBHLAP-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | UNBQMQJVNBHLAP-UHFFFAOYSA-N |